← Evidence map

ArticleCurrent urology2023

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.

Jun Teishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37692134